Ebolaviruses, Marburg virus, Nipah virus, Hendra virus, Lassa virus, BSL-4 pathogens, emerging viruses, nonhuman primate models, development of vaccines and therapeutics, spatial biology

Dr. Woolsey’s research focuses on understanding the immunopathology of emerging and re-emerging viruses requiring maximum biocontainment (BSL-4). She employs advanced immunological tools such as spectral cytometry/sorting and spatial biology to dissect natural and vaccine-mediated host immunity to these pathogens. The overall objective is to harness this knowledge to improve medical countermeasures. Her specific interests include 1) generating rapid-acting and durable recombinant Vesicular stomatitis virus (rVSV)-based vaccines, 2) characterizing how these vaccines elicit early and sustained protection, and 3) exploring mechanisms of virus persistence and sequelae

PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=woolsey+courtney
Research Experts: https://researchexperts.utmb.edu/en/persons/courtney-woolsey